{"id":440403,"date":"2024-10-20T08:14:43","date_gmt":"2024-10-20T08:14:43","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-23-30468236-dc-2023\/"},"modified":"2024-10-26T15:25:06","modified_gmt":"2024-10-26T15:25:06","slug":"bsi-23-30468236-dc-2023","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-23-30468236-dc-2023\/","title":{"rendered":"BSI 23\/30468236 DC 2023"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | 30468236-NC.pdf <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | 65A_1102e_CDV.pdf <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | FOREWORD <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1. Scope 2. Normative references 3. Terms and definitions <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3.1 Terms and definitions <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 3.2 Abbreviations <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 4. General 4.101 Essential Performance 4.102 Basic Safety <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 5. EMC test plan 5.1 General 5.2 Configuration of EUT during testing <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 5.2.101 Subsystems 5.3 Operation conditions of EUT during testing 5.3.101 Operation conditions 5.4 Specification of functional performance 5.5 Test description <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 6. Immunity requirements 6.1 Conditions during the tests 6.101 Conditions during the tests 6.2 Immunity test requirements 6.201 Risk assessment and consideration of EMC immunity requirements <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6.3 Random aspects 6.4 Performance criteria 6.401 Pass\/fail criteria <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 7. Emission requirements 8. Test results and test report <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 9. Instructions for use 9.101 General requirements for the ivd mee instructions for use <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 9.102 Additional requirements for the instructions for use for equipment to be used in a home healthcare environment 9.103 Additional requirements for the instructions for use for equipment to be used in a professional healthcare facility environment <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Annex A (normative) Immunity test requirements for portable test and measurement equipment powered by battery or from the circuit being measured <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | Annex B (informative) General guidance and rationale B.1 Background for maintenance leading to edition 4 of this standard <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | Annex C (informative) How to apply this standard and its environments <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | Annex D (informative) (leveraged from IEC 60601-1-2:2020 Annex G) Guidance: Test plan D.1 Test plan contents <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | Annex E (informative) (leveraged from IEC 60601-1-2:2020 Table 1) Table E.1 \u2013 Power input voltages and frequencies during the tests (1 of 2) <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | Annex F (informative) Guidance on the application of risk management with regard to Electromagnetic Disturbances and the Identification of Immunity pass\/fail criteria risks of EUT to identify critical immunity testing F.1 Immunity pass\/fail criteria principles F.1.1 General F.1.2 Immunity pass\/fail criteria for non-ivd mee used in an ivd mee F.1.3 Immunity pass\/fail criteria determination F.2 Basic safety <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | F.3 ESSENTIAL PERFORMANCE <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | F.4 Immunity pass\/fail criteria examples F.4.1 General examples <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | F.4.2 essential performance Immunity pass criteria examples for IVD Immunoassay Analyzer <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" BS EN IEC 61326-2-6. Electrical equipment for measurement, control and laboratory use. EMC requirements – Part 2-6. Particular requirements. In vitro diagnostic (IVD) medical equipment<\/b><\/p>\n |